Clinical trial · Interventional
A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy
NCT05755594CI-TRIAL-00064482not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Further studies are needed to investigate the prognosis and perioperative safety of patients undergoing robotic-assisted pancreaticoduodenectomy. In this study, clinical data and prognostic data of patients undergoing this procedure were prospectively collected and analyzed to explore its safety and efficacy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Common Bile Duct Diseases | — | UNRESOLVED | — |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
| Periampullary Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Robot-assisted Pancreaticoduodenectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Robot-assisted Pancreaticoduodenectomy
- description
- By performing pancreaticoduodenectomy on the subject using the latest generation Da Vinci robotic surgical system and assisted by another surgeon for the entire procedure
- interventionNames
- Procedure: Robot-assisted Pancreaticoduodenectomy
Primary outcomes (1)
- measure
- Rate of long-term Survival
- timeFrame
- 3 years
- description
- survival will be documented 3 years after surgery
Secondary outcomes (2)
- measure
- Unplanned re-admission rate after discharge within 30 days
- timeFrame
- 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years old * Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy * No distant transfer * No significant vascular invasion was received Exclusion Criteria: * With tumors of other organs * Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs * Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery * Preoperative adjuvant therapy was given
References
Publications (0)
Data not yet available
No reference posted for this study.